ChromaTan
PrivateLast Round
Grant
Mar 17, 2025
Total Funding Raised
$13.1M
Company Overview
ChromaTan operates in Healthcare & Life Sciences and is based in Pennsylvania. Its latest recorded funding round was a Grant round in March 2025.
ChromaTan is a biotechnology company that develops continuous, column-free chromatography solutions for bioprocessing and biologics manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChromaTan Comparables
Compare ChromaTan with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| YMC Co., Ltd. | 73% | |
| Danaher | 72% | |
| Merck | 72% |
For institutional investors. Book with your work email.
ChromaTan Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 17, 2025 | ||||
| Grant | May 30, 2024 | ||||
| Debt | Feb 6, 2023 | ||||
| Grant | Sep 21, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ChromaTan Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Benjamin Franklin Technology Partners | Debt, Series A |
| Ben Franklin Technology Partners of Central & Northern PA | Series A |
| Food and Drug Administration | Grant |
| National Institute of General Medical Sciences | Grant |
| Lehigh Valley Angel Investors | Series A |
| Zoic Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 48% MoM.
- Apr 6, 2026
Monthly visitors grew 159% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
ChromaTan Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ChromaTan's valuation, stock price, and market status.
Is ChromaTan a public or private company?
ChromaTan is a private company.
What is the current stock price of ChromaTan?
ChromaTan is a private company, so its shares have no public market price. Caplight tracks ChromaTan's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ChromaTan worth (valuation)?
Valuation information for ChromaTan is not publicly available.
Can I buy ChromaTan stock?
ChromaTan shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ChromaTan's last funding round?
ChromaTan's most recent funding round was Grant on March 17, 2025.
Who are the main investors in ChromaTan?
Key investors in ChromaTan include Benjamin Franklin Technology Partners, Ben Franklin Technology Partners of Central & Northern PA, Food and Drug Administration, National Institute of General Medical Sciences, Lehigh Valley Angel Investors.
Will ChromaTan IPO soon?
No public IPO plans have been announced for ChromaTan.
How can I track ChromaTan secondary market activity?
Caplight tracks bids, offers, and trades in ChromaTan's shares on secondary markets.